King Luther Capital Management Corp Biomarin Pharmaceutical Inc Transaction History
King Luther Capital Management Corp
- $23 Billion
- Q3 2024
A detailed history of King Luther Capital Management Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, King Luther Capital Management Corp holds 28,840 shares of BMRN stock, worth $1.91 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
28,840Holding current value
$1.91 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
637Shares Held
177MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.51 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.28 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.25 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$921 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$696 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...